Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

Dyslipidemia is a major traditional risk factor for cardiovascular disease (CVD) in chronic kidney disease (CKD) patients, although the altered lipid profile does not explain the number and severity of CVD events. High-density lipoprotein (HDL) is a heterogeneous (size, composition, and functionalit...

Full description

Bibliographic Details
Main Authors:	Susana Coimbra, Flávio Reis, Maria João Valente, Susana Rocha, Cristina Catarino, Petronila Rocha-Pereira, Maria Sameiro-Faria, Elsa Bronze-da-Rocha, Luís Belo, Alice Santos-Silva
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Biomedicines
Subjects:	HDL subpopulations cardiovascular disease risk chronic kidney disease inflammation oxidative stress HDL functionality
Online Access:	https://www.mdpi.com/2227-9059/9/5/554

Similar Items

The metabolism and anti-atherogenic properties of HDL
by: Kerry-Anne Rye, et al.
Published: (2009-01-01)

Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations
by: Maharajah Ponnaiah, et al.
Published: (2024-03-01)

Structure and intermolecular interactions in spheroidal high-density lipoprotein subpopulations
by: Chris J. Malajczuk, et al.
Published: (2021-01-01)

Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study
by: Setor K. Kunutsor, et al.
Published: (2024-02-01)

Role of LCAT in HDL remodeling: investigation of LCAT deficiency states
by: Bela F. Asztalos, et al.
Published: (2007-03-01)

Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation
by: Elisa Dietrich, et al.
Published: (2022-10-01)

High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions
by: Athina Trakaki, et al.
Published: (2020-12-01)

Novel Size‐Based High‐Density Lipoprotein Subspecies and Incident Vascular Events
by: Austin Deets, et al.
Published: (2023-11-01)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023-06-01)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
by: Ewa Wieczorek, et al.
Published: (2021-12-01)

Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease
by: Long Jieni, et al.
Published: (2021-11-01)

Relationship between High-Density Lipoprotein and C-reactive Protein in Patients with Atherosclerosis
by: E Abdollahi, et al.
Published: (2014-08-01)

High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
by: Andrea Bonnin Márquez, et al.
Published: (2020-11-01)

A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins
by: Ming Ding, et al.
Published: (2020-04-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

Pharmacological Intervention to Modulate HDL: What Do We Target?
by: Nicholas J. Woudberg, et al.
Published: (2018-01-01)

High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training
by: Nayoung Ahn, et al.
Published: (2016-09-01)

High ratio of triglycerides to hdl-cholesterol predicts extensive coronary disease
by: Protasio Lemos da Luz, et al.
Published: (2008-01-01)

Functional diversity of high-density lipoproteins: finding the golden mean
by: V. A. Metelskaya
Published: (2021-06-01)

Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
by: Leonie Schoch, et al.
Published: (2021-07-01)

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
by: Constantine E. Kosmas, et al.
Published: (2023-03-01)

High-Density Lipoprotein Cholosterol May Discriminate Mild and Severe Preeclampsia
by: Esra Can, et al.
Published: (2011-08-01)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
by: Veronika Vyletelová, et al.
Published: (2022-10-01)

How good can HDL Cholesterol be? Recent Evidence and way forward for Clinical Practice
by: Sikandar Hayat Khan
Published: (2023-06-01)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
by: Kyung-Hyun Cho
Published: (2022-04-01)

High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
by: Sara Sokooti, et al.
Published: (2020-03-01)

Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol
by: Geevar Zachariah
Published: (2024-03-01)

Correlation between the High Density Lipoprotein and its Subtypes in Coronary Heart Disease
by: Fen Gao, et al.
Published: (2016-05-01)

Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients
by: Ramachandran Kaliaperumal, et al.
Published: (2014-02-01)

High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
by: Knut Tore Lappegård, et al.
Published: (2021-07-01)

HDL and chronic kidney disease
by: Chiara Pavanello, et al.
Published: (2023-06-01)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
by: Diego Estrada-Luna, et al.
Published: (2018-10-01)

High-density lipoprotein (HDL) cholesterol – more complicated than we think?
by: Katarzyna Nessler, et al.
Published: (2018-09-01)

High-Density Lipoprotein Changes in Alzheimer’s Disease Are <i>APOE</i> Genotype-Specific
by: Brian V. Hong, et al.
Published: (2022-06-01)

Altered HDL proteome predicts incident CVD in chronic kidney disease patients
by: Baohai Shao, et al.
Published: (2021-01-01)

Regular Practice of Physical Activity Improves Cholesterol Transfers to High-Density Lipoprotein (HDL) and Other HDL Metabolic Parameters in Older Adults
by: Pedro G. S. Braga, et al.
Published: (2023-11-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)

Effects of Different Intensities of Circuit Resistance Training on Plasma level of High-Density Lipoprotein Subfractions and Apolipoprotein M in Untrained Young Men
by: Abolfazle Aghababaeian, et al.
Published: (2019-09-01)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
by: Manuela Casula, et al.
Published: (2021-07-01)

Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis
by: Tianhua Zhang, et al.
Published: (2019-12-01)